PMID- 24133925 OWN - NLM STAT- MEDLINE DCOM- 20131101 LR - 20191112 IS - 1433-6510 (Print) IS - 1433-6510 (Linking) VI - 59 IP - 7-8 DP - 2013 TI - Evaluation of three APTT reagents in a routine laboratory: toward a compromise. PG - 921-4 AB - BACKGROUND: Our current activated partial thromboplastin time (APTT) reagent (PTT-A) is often prolonged for unexplained reasons. METHODS: We decided to compare this reagent with an alternative reagent (Cephascreen) and with our second line APTT (Actin FS) in terms of cut-off values, sensitivity to in-vitro coagulation factor deficiencies, sensitivity to lupus anticoagulant (LA), and in vivo sensitivity to unfractionated heparin (UFH). RESULTS: Actin FS, PTT-A, and Cephascreen were prolonged for FVIII level at 60%, 40%, and 40% respectively, FIX at 50%, 25%, and 35%, and FXI at 60%, 20%, and 50%. PTT-A showed the same sensitivity and specificity as Cephascreen to LA. Actin FS and PTT-A appeared less suitable to monitor UFH regarding the CLSI criteria. CONCLUSIONS: Cephascreen fulfilled the CLSI performance criteria, with a good compromise in terms of sensitivity to factor deficiency and with a substantial reduction of complementary analysis in our routine practice. FAU - Rozen, Laurence AU - Rozen L AD - Laboratory of Hematology and Haemostasis, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. laurence.rozen@chu-brugmann.be FAU - Copette, Florian AU - Copette F FAU - Noubouossie, Denis F AU - Noubouossie DF FAU - Demulder, Anne AU - Demulder A LA - eng PT - Journal Article PL - Germany TA - Clin Lab JT - Clinical laboratory JID - 9705611 RN - 0 (Indicators and Reagents) SB - IM MH - Humans MH - *Indicators and Reagents MH - *Partial Thromboplastin Time EDAT- 2013/10/19 06:00 MHDA- 2013/11/02 06:00 CRDT- 2013/10/19 06:00 PHST- 2013/10/19 06:00 [entrez] PHST- 2013/10/19 06:00 [pubmed] PHST- 2013/11/02 06:00 [medline] AID - 10.7754/clin.lab.2012.120909 [doi] PST - ppublish SO - Clin Lab. 2013;59(7-8):921-4. doi: 10.7754/clin.lab.2012.120909.